Skip to main content

Table 1 Acquired Homotypic and Heterotypic Immunity Against Oculogenital Chlamydia trachomatis Serovars Following Female Genital Tract Infection in Mice

From: Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice

Infection Serovar Number of Animals Number of Animals Culture Positive on Reinfection Day Median Duration of Infection Wilcoxon Rank Sum p Value
Initial1 Reinfection   2 4 6 8 10 14 17 21 24 28 31 35 38 42 45 48 52 55   
D H 12 12 5 3 2 5 2 1 0 0 0 0 0 0 0 0 0 0 0 5 <0.01
H H 12 12 11 8 8 10 3 1 2 0 0 0 0 0 0 0 0 0 0 10 ~0.10
None H 12 12 12 12 12 11 6 5 2 2 1 0 0 1 0 0 0 0 0 15.5 --
D D 12 12 9 7 9 7 5 4 2 2 1 0 0 0 0 0 0 0 0 12 <0.01
H D 12 12 12 12 12 11 6 10 7 7 4 1 2 1 0 0 0 0 0 24 NS
None D 12 12 12 12 12 11 7 5 6 4 4 2 1 1 2 0 0 0 0 22.5 --
  1. 1Median duration of infections during the primary infection phase of this study were 10 days with serovar H and 33 days with serovar D.